Neurology:原发性脑出血前,血脂水平呈亚急性下降

2016-07-10 phylis 译 MedSci原创

目的:研究者旨在描述在脑出血(脑出血)患者的循环血脂水平的时间变化,并探讨其与脑出血风险。方法:这是一项单中心、回顾性,纵向的病例对照研究,原发性脑出血和对照组受试者来源于医院临床数据登记记录。应用分段线性混合效应随机系数模型,以确定血脂变化对脑出血风险的影响。结果:212例脑出血病例和301例对照组患者纳入分析。,脑出血患者和非脑出血组对照组血清总胆固醇(TC)和低密度脂蛋白(LDL)水平的总体

目的:研究者旨在描述脑出血(脑出血)患者的循环血脂水平的时间变化,并探讨其与脑出血风险的关系。

方法:这是一项单中心、回顾性,纵向的病例对照研究,原发性脑出血和对照组受试者来源于医院临床数据登记记录。应用分段线性混合效应随机系数模型,以确定血脂变化对脑出血风险的影响。

结果:212例脑出血病例和301例对照组患者纳入分析。脑出血患者和非脑出血组对照组血清总胆固醇(TC)和低密度脂蛋白(LDL)水平的总体趋势不同。与出血前6个月到24个月之间相比,脑出血患者在ICH前6个月血清TC和LDL水平增加下降(TC:-29.25mg/dL;低密度脂蛋白:-21.48 mg/dL),而在非ICH对照组没观察到这种现象。亚组分析证实,这种现象不能归因于他汀类药物或酒精暴露。两组间甘油三酯和高密度脂蛋白的趋势没有显著差异。

结论:ICH组和非ICH组,纵向血脂水平不同,最显著的是,独立于他汀类药物或酒精使用,ICH前6个月内,血清胆固醇和低密度脂蛋白水平下降。总胆固醇和低密度脂蛋白的变化趋势表明,物脑出血的发生的可能生物途径。需要进一步的研究来重复这些结果,将血脂的的变化作为的急性脑损伤潜在的生物标志物。

原始出处:

Phuah CL, Raffeld MR, et al.Subacute decline in serum lipids precedes the occurrence of primary intracerebral hemorrhage.Neurology. 2016 May 31.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1812580, encodeId=e08f18125806f, content=<a href='/topic/show?id=90a589932ef' target=_blank style='color:#2F92EE;'>#血脂水#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89932, encryptionId=90a589932ef, topicName=血脂水)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat Mar 18 20:48:00 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999723, encodeId=604b1999e23c2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Feb 09 10:48:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949713, encodeId=626e1949e1319, content=<a href='/topic/show?id=a91e3e11312' target=_blank style='color:#2F92EE;'>#原发性脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37113, encryptionId=a91e3e11312, topicName=原发性脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Mar 27 10:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846494, encodeId=defe1846494c6, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Mar 16 07:48:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640790, encodeId=2eea1640e90a4, content=<a href='/topic/show?id=eade8993345' target=_blank style='color:#2F92EE;'>#血脂水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89933, encryptionId=eade8993345, topicName=血脂水平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60d022728662, createdName=12498b3em15(暂无昵称), createdTime=Thu Nov 17 07:48:00 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92761, encodeId=ad7692e61ca, content=学习了,再研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Jul 11 13:58:00 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1812580, encodeId=e08f18125806f, content=<a href='/topic/show?id=90a589932ef' target=_blank style='color:#2F92EE;'>#血脂水#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89932, encryptionId=90a589932ef, topicName=血脂水)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat Mar 18 20:48:00 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999723, encodeId=604b1999e23c2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Feb 09 10:48:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949713, encodeId=626e1949e1319, content=<a href='/topic/show?id=a91e3e11312' target=_blank style='color:#2F92EE;'>#原发性脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37113, encryptionId=a91e3e11312, topicName=原发性脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Mar 27 10:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846494, encodeId=defe1846494c6, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Mar 16 07:48:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640790, encodeId=2eea1640e90a4, content=<a href='/topic/show?id=eade8993345' target=_blank style='color:#2F92EE;'>#血脂水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89933, encryptionId=eade8993345, topicName=血脂水平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60d022728662, createdName=12498b3em15(暂无昵称), createdTime=Thu Nov 17 07:48:00 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92761, encodeId=ad7692e61ca, content=学习了,再研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Jul 11 13:58:00 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
    2017-02-09 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=1812580, encodeId=e08f18125806f, content=<a href='/topic/show?id=90a589932ef' target=_blank style='color:#2F92EE;'>#血脂水#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89932, encryptionId=90a589932ef, topicName=血脂水)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat Mar 18 20:48:00 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999723, encodeId=604b1999e23c2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Feb 09 10:48:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949713, encodeId=626e1949e1319, content=<a href='/topic/show?id=a91e3e11312' target=_blank style='color:#2F92EE;'>#原发性脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37113, encryptionId=a91e3e11312, topicName=原发性脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Mar 27 10:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846494, encodeId=defe1846494c6, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Mar 16 07:48:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640790, encodeId=2eea1640e90a4, content=<a href='/topic/show?id=eade8993345' target=_blank style='color:#2F92EE;'>#血脂水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89933, encryptionId=eade8993345, topicName=血脂水平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60d022728662, createdName=12498b3em15(暂无昵称), createdTime=Thu Nov 17 07:48:00 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92761, encodeId=ad7692e61ca, content=学习了,再研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Jul 11 13:58:00 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1812580, encodeId=e08f18125806f, content=<a href='/topic/show?id=90a589932ef' target=_blank style='color:#2F92EE;'>#血脂水#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89932, encryptionId=90a589932ef, topicName=血脂水)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat Mar 18 20:48:00 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999723, encodeId=604b1999e23c2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Feb 09 10:48:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949713, encodeId=626e1949e1319, content=<a href='/topic/show?id=a91e3e11312' target=_blank style='color:#2F92EE;'>#原发性脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37113, encryptionId=a91e3e11312, topicName=原发性脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Mar 27 10:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846494, encodeId=defe1846494c6, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Mar 16 07:48:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640790, encodeId=2eea1640e90a4, content=<a href='/topic/show?id=eade8993345' target=_blank style='color:#2F92EE;'>#血脂水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89933, encryptionId=eade8993345, topicName=血脂水平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60d022728662, createdName=12498b3em15(暂无昵称), createdTime=Thu Nov 17 07:48:00 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92761, encodeId=ad7692e61ca, content=学习了,再研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Jul 11 13:58:00 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1812580, encodeId=e08f18125806f, content=<a href='/topic/show?id=90a589932ef' target=_blank style='color:#2F92EE;'>#血脂水#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89932, encryptionId=90a589932ef, topicName=血脂水)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat Mar 18 20:48:00 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999723, encodeId=604b1999e23c2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Feb 09 10:48:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949713, encodeId=626e1949e1319, content=<a href='/topic/show?id=a91e3e11312' target=_blank style='color:#2F92EE;'>#原发性脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37113, encryptionId=a91e3e11312, topicName=原发性脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Mar 27 10:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846494, encodeId=defe1846494c6, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Mar 16 07:48:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640790, encodeId=2eea1640e90a4, content=<a href='/topic/show?id=eade8993345' target=_blank style='color:#2F92EE;'>#血脂水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89933, encryptionId=eade8993345, topicName=血脂水平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60d022728662, createdName=12498b3em15(暂无昵称), createdTime=Thu Nov 17 07:48:00 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92761, encodeId=ad7692e61ca, content=学习了,再研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Jul 11 13:58:00 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1812580, encodeId=e08f18125806f, content=<a href='/topic/show?id=90a589932ef' target=_blank style='color:#2F92EE;'>#血脂水#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89932, encryptionId=90a589932ef, topicName=血脂水)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat Mar 18 20:48:00 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999723, encodeId=604b1999e23c2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Feb 09 10:48:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949713, encodeId=626e1949e1319, content=<a href='/topic/show?id=a91e3e11312' target=_blank style='color:#2F92EE;'>#原发性脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37113, encryptionId=a91e3e11312, topicName=原发性脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Mar 27 10:48:00 CST 2017, time=2017-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1846494, encodeId=defe1846494c6, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Mar 16 07:48:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640790, encodeId=2eea1640e90a4, content=<a href='/topic/show?id=eade8993345' target=_blank style='color:#2F92EE;'>#血脂水平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89933, encryptionId=eade8993345, topicName=血脂水平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60d022728662, createdName=12498b3em15(暂无昵称), createdTime=Thu Nov 17 07:48:00 CST 2016, time=2016-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92761, encodeId=ad7692e61ca, content=学习了,再研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Mon Jul 11 13:58:00 CST 2016, time=2016-07-11, status=1, ipAttribution=)]
    2016-07-11 明崖

    学习了,再研究

    0

相关资讯

PLoS One:H-ATOMIC标准用于脑出血患者病因分类

背景:目前脑出血(ICH)尚没有一个普遍接受的病因分类标准。为此,研究者开发了一套病因标准并应用于大量的患者确定其效用。方法:H-ATOMIC分类包括7类病因:高血压,脑淀粉样血管病、肿瘤、口服抗凝药、血管畸形,罕见的原因和原因不明。对于每一个类别,病因评分可分为3个等级:可能(3),非常可能(2),明确病因(1)。当得分表明存在结构异常时,研究者旨在进行一项包括神经影像学、血液检查、CT血管造影

Neurology:脑出血人口学特征、部位、血管危险因素存在性别差异

背景:脑出血相关的性别差异的信息较少。这是一项前瞻性观察研究来描述原发性脑出血人口统计学,血管危险因素及卒中护理和预后的性别差异。方法:BasicMar登记入住公立医院的卒中患者的记录,共覆盖人口330000。从2005到2015年,共有515例急性原发性脑出血患者。获得3个月预后记录。结果:发生脑出血男性高于女性(52.4% vs 47.6%);发生脑出血的女性年龄高于男性,女性以前功能状态更差

Stroke:未破裂脑动静脉畸形的患者可行立体定向放射治疗

背景:未破裂脑动静脉畸形的随机试验(ARUBA)表明医疗处理对卒中和其他神经功能的缺损方面优于不处理。研究者旨在验证立体定向放射手术(SRS)处理未破裂脑动静脉畸形的可行性。方法:回顾性分析292例未破裂脑动静脉畸形行SRS治疗的患者。比较行SRS前后,脑出血的风险。结果: 存在动静脉畸形,初步诊断时尚未破裂的患者292例,17例在诊断和初始治疗干预之间存在脑出血(年出血率,2.1%;95% CI

Stroke: 脑出血不规则的形状与预后独立相关(INTERACT2试验)

背景:急性脑出血患者,血肿的形态和密度与其随后的增长相关,但这些因素对临床预后的影响不确定的。方法: 急性脑出血强化降压(INTERACT2)试验中获得CT扫描和临床资料。三个独立的神经学家应用量表独立的评估ICH的形状和密度。当ICH存在≥2椭球形ICH,定义为不规则形状。ICH时存在≥3低密度病灶,定义为密度不均匀。预后为90天随机化后,死亡和重大残疾(改良Rankin量表评分3-5分)。应用

Stroke: 脑出血患者出院后,可口服抗凝剂治疗

背景:脑出血史患者抗栓治疗(AT)的有效性和安全性尚不清楚。因此,研究者确定首次脑出血住院患者适合AT普遍性,并且检测应用AT对长期临床预后的影响。方法:研究者使用全国范围内丹麦医疗登记进行一项基于人群的队列研究。确定因ICH入院后30天,有血栓栓塞的风险的幸存者,并进行随访。研究者根据AT的应用评估全因死亡,血栓栓塞事件或主要出血的HR值。结果:研究者在2005和2013间确定了6369例患者。

Stroke:心肌梗死幸存者,卒中发生的长期风险(30年队列研究)

背景:心肌梗死(MI)后改善生存可增加心肌梗死后卒中的风险。研究者调查了与一般人群相比,心肌梗死的患者发生缺血性卒中,脑出血(ICH),蛛网膜下腔出血(SAH)的风险。方法:研究者使用丹麦的医疗登记记录进行了一项全国性的以人群为基础的队列研究。在1980至2009年间,研究者确定了第一次住院诊断为心肌梗死的患者,并形成了按照性别和年龄匹配的对照组。研究者计算累积卒中风险和校正后的卒中RR值及95%